[ad_1]
In total, several dozen reports of adverse reactions have been received since the start of the COVID-19 vaccination, with people reporting high fever and nausea for several days.
According to Rugilė Pilvinienė, Senior Advisor to the Pharmacovigilance and Poisoning Information Division of the State Medicines Control Agency (IARC), more such reports were received after the start of the second dose of vaccination.
“We are seeing a trend that after receiving the second dose of vaccination, we have received more reports of adverse reactions than during the same period after the first dose of vaccination,” he said.
According to the IWT representative, the trend for adverse reactions to be reported more frequently after the second dose was also seen in clinical trials and was reported in the BioNTech and Pfizer Summary of Product Characteristics.
We see a trend that after receiving the second dose of vaccination, we receive more reports of adverse reactions than during the same period after the first dose of vaccination.
“In principle, the fact that this will be the case has already been predicted in clinical trials and is directly and clearly established,” he said.
According to R. Pilvinienė, most of the reports referred to local side effects: hand pain, swelling of the lymph nodes on the side where the vaccine is administered. Systemic reactions such as fever are not predominant.
However, according to her, there were cases where people reported high fever, 38-39 degrees, severe headache, vomiting, but they occurred in units.
“There were people who reported vomiting, one report was that the person felt very bad and had a headache, he requested it to the admissions department. However, we have no data that they needed hospitalization, long-term treatment, “said an IWT representative.
All reported adverse reactions resolved within a few days, after which the person felt normal.
There have also been several reports of hypotension in humans immediately after vaccination, but no data is yet available on whether this could have been an acute allergic reaction. The individuals passed out and were assisted in the vaccination facilities.
Hospital: reaction occurred in a small proportion of staff
LSMU Kaunas Clinical Hospital, whose doctors are among those who received the second dose of the vaccine, informed the BNS that there were no unexpected reactions to the vaccine and that a small part of the hospital staff had a mild to moderate reaction.
According to the hospital, after the first vaccination, almost no one experienced a reaction, after the second vaccination, some workers experienced one or more of the symptoms specified by the manufacturer, such as pain at the injection site, fatigue, headache , muscle, joint pain, chills, fever. They, according to the manufacturer, passed after a day or two.
According to Rita Butylkina, head of the Infection Control Department at LSMU Kaunas Hospital, about 2-3 percent felt these reactions. vaccinated staff.
“Some people who have been vaccinated, including myself, have not experienced any reaction to the vaccine,” says Butylkina.
All LSMU Kaunas Hospital employees who have been vaccinated with COVID-19 for the second time are currently working. 1.7 thousand received the first vaccine. employees, the second – 454. Vaccination in the institution is carried out in stages.
According to R. Pilvinienė, data from clinical trials of the vaccine show which adverse reactions were more frequent in younger patients, such as axillary swelling, fatigue, headache, muscle and joint pain, chills, nausea, vomiting.
Regarding COVID-19 vaccines, IWT received more reports than usual, but Ms Pilvinienė noted that the service had been active to encourage it to do so, and that the vaccine was new and of great public interest, so it was likely also contributed to the more frequently reported adverse reactions.
According to data published by the Department of Statistics, almost 58 thousand people have received the first COVID-19 vaccine. people, the second – 9 thousand. people.
[ad_2]
